PACIFIC SHUANGLIN BIO-PHARMACY CO., LTD |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 29.34 CNY | -0.98% |
|
-1.11% | +7.71% |
| Apr. 15 | Pacific Shuanglin Bio-pharmacy's 2023 Profit Jumps 4% Despite Lower Revenue; Shares Rise 4% | MT |
| Apr. 15 | Pacific Shuanglin Bio-pharmacy's Profit Seen More Than Doubling in Q1; Shares Up 3% | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration
Pacific Shuanglin Bio pharmacy Co Ltd, formerly Southern Shuanglin Bio-pharmacy Co Ltd, formerly Zhenxing Biopharmaceutical & Chemical Co., Ltd., is a China-based company mainly engaged in the research, development, production and sales of blood products. The Company's main products are human albumin, intravenous immunoglobulin (pH4), human immunoglobulin, hepatitis B human immunoglobulin, tetanus immunoglobulin and rabies immunoglobulin. The Company mainly operates its business in the domestic market.
Sector
Pharmaceuticals
Calendar
2024-04-26
- Q4 2023 Earnings Release
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
29.34
CNY
Average target price
25.94
CNY
Spread / Average Target
-11.59%
EPS Revisions
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| +7.71% | 3B | |
| -2.50% | 85.68B | |
| +4.08% | 41.4B | |
| -25.35% | 28.22B | |
| +54.31% | 24.64B | |
| -4.52% | 16.98B | |
| -42.09% | 13.29B | |
| -17.77% | 11.66B | |
| -12.10% | 11.65B | |
| +0.75% | 8.18B |
- Stock Market
- Equities
- 000403 Stock
- News Pacific Shuanglin Bio-pharmacy Co., LTD
- Pacific Shuanglin Bio-pharmacy Signs Drug Supply, Distribution Deal With Brazil’s Hypera Pharma
